Jim Simons Phathom Pharmaceuticals, Inc. Transaction History

Renaissance Technologies LLC

  • $63.1 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024
BUY
$6.99 - $10.71 $458,544 - $702,576
65,600 New
65,600 $599,000
Q2 2023

Aug 11, 2023
BUY
$7.28 - $14.32 $72,800 - $143,200
10,000 New
10,000 $143,000
Q2 2022

Aug 12, 2022
BUY
$6.2 - $15.5 $148,800 - $372,000
24,000 New
24,000 $203,000
Q2 2021

Aug 13, 2021
SELL
$32.66 - $39.87 $369,057 - $450,531
-11,300 Closed
0 $0
Q1 2021

May 13, 2021
BUY
$33.86 - $48.68 $382,618 - $550,084
11,300 New
11,300 $424,000

Others Institutions Holding PHAT

# of Institutions
143
Shares Held
74.8M
Call Options Held
42.3K
Put Options Held
45.7K
View Full List

About Phathom Pharmaceuticals, Inc.

PHAT Quotes by TradingView
  • Ticker PHAT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,175,200
  • Market Cap $272M
  • Description
  • Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also develo...
More about PHAT
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email